Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Mankind Pharma using IBM cloud technology to drive business growth - The Pharma Times | Pharma & Health Care News Portal
Categories: IT & Software Support

Mankind Pharma using IBM cloud technology to drive business growth


Bangalore, May 21, 2014:
IBM (NYSE: IBM) today announced that Mankind Pharma, a leading pharmaceutical company in India, has selected SoftLayer’s cloud platform to support its business growth and expansion. SoftLayer, an IBM company, will enable Mankind Pharma to significantly improve the performance of its business critical applications and scale the use of these applications across multiple locations.

Founded in 1995, Mankind Pharma has grown rapidly in the last decade and is currently among the top five fastest growing pharmaceutical companies in India with an employee base of over 9,000, a turnover of INR 2800 crores and 15 manufacturing plants. Mankind Pharma is a fully integrated pharmaceutical company, with a comprehensive network of 60 C&F (Carrying & Forwarding) agents and over 6,000 stockiest.

 

Given the exponential growth, Mankind Pharma wanted to align its IT infrastructure with the business goals of the company, while keeping operations and capital expenditures to a minimum. The company also wanted an IT infrastructure to scale based on the seasonal peaks and troughs of the pharmaceutical business.

 

SoftLayer’s infrastructure was chosen as the ideal solution to fit the business needs of Mankind Pharma. It ensured scalability of the infrastructure depending on Mankind Pharma’s changing business needs. Since these business critical applications are designed to meet the growing needs of its key stakeholders, it becomes mission-critical for Mankind Pharma to deploy the right amount of compute to run seamless operations. SoftLayer cloud provided the perfect combination of pay-as-you-use option as well as scalability to suit business need.

 

“We chose SoftLayer as a service which helped us deploy our business critical application on Cloud which required a highly scalable infrastructure to meet the ongoing demands of the market. SoftLayer is geared to meet these requirements and help us continue our strong business momentum and provide greater client satisfaction,” said Pramod Gokhale, Vice President-Information Services & Strategy, Mankind Pharma.

 

Apart from scaling operations during peak months, the SoftLayer infrastructure will also help Mankind Pharma scale up quickly when it expands operations to international markets.

 

“IBM has been a strategic partner of Mankind Pharma for a long time and it is exciting to see our engagement is expanding on to cloud. With SoftLayer, IBM is focused on providing higher value and delivering unmatched expertise and capabilities to help clients tackle business specific challenges with cloud. With SoftLayer cloud, Mankind Pharma can have a better control on their operations to drive business growth,” said Ganesh Margabandhu, General Manager, Global Technology Services, IBM India South Asia. CCI Newswire

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

4 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

6 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago